gluten-containing	placebo	bloating - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	498	584	148 IBS patients fulfilling the Rome III criteria were enrolled between 2011 and 2013.
gluten-containing	placebo	bloating - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	12040	12444	The statistical analysis showed that the differences between gluten-containing and placebo groups in the overall symptoms (placebo (16.2%), gluten (74.3%)) including satisfaction with stool consistency (placebo (8.1%), gluten (77.1%)), tiredness (placebo (8.8%), gluten (60%)), nausea (placebo (5.4%), gluten (8.3%)), bloating (placebo (16.2%), gluten (74.3%)) were statistically significant (p = 0.001).
gluten-containing	placebo	bloating - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	585	692	However, only 72 out of the 148 commenced on a gluten-free diet for up to six weeks and completed the study
gluten-containing	placebo	tiredness - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	12040	12444	The statistical analysis showed that the differences between gluten-containing and placebo groups in the overall symptoms (placebo (16.2%), gluten (74.3%)) including satisfaction with stool consistency (placebo (8.1%), gluten (77.1%)), tiredness (placebo (8.8%), gluten (60%)), nausea (placebo (5.4%), gluten (8.3%)), bloating (placebo (16.2%), gluten (74.3%)) were statistically significant (p = 0.001).
gluten-containing	placebo	bloating - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	781	1046	In the second stage after six weeks, patients whose symptoms improved to an acceptable level were randomly divided into two groups; patients either received packages containing powdered gluten (35 cases) or patients received placebo (gluten free powder) (37 cases).
gluten-containing	placebo	overall symptoms - effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS	12040	12444	The statistical analysis showed that the differences between gluten-containing and placebo groups in the overall symptoms (placebo (16.2%), gluten (74.3%)) including satisfaction with stool consistency (placebo (8.1%), gluten (77.1%)), tiredness (placebo (8.8%), gluten (60%)), nausea (placebo (5.4%), gluten (8.3%)), bloating (placebo (16.2%), gluten (74.3%)) were statistically significant (p = 0.001).
